Literature DB >> 19843403

Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review.

John G Kemp1, Timothy J Craig.   

Abstract

Hereditary angioedema (HAE) is a rare disease caused by deficiency in the production or function of C1 inhibitor. It predisposes individuals to paroxysmal acute attacks causing painful, debilitating, disfiguring, and life-threatening angioedema. Prodromes occurring hours to days before attacks have been described in the literature; however, their significance as predictive signals of impending attacks is uncertain. Given the morbidity and mortality associated with HAE attacks and the increasing availability of therapeutic products for their treatment, identifying prodromes that accurately predict the onset of attacks could provide the basis for the development of a validated instrument to identify the onset of such attacks requiring abortive therapeutic intervention before the development of clinically significant angioedema. The aim of this study was to review the literature to identify the prodromes reported to occur with HAE attacks. A literature review of English language journal articles was performed using search terms hereditary angioedema, HAE, angioneurotic edema, prodrome, signs, and symptoms. Nineteen original English language articles that included both case reports and studies describing prodromes associated with HAE attacks were obtained. Our review indicates that there is significant variability in the expression, manifestation, prevalence, timing, and predictive reliability of the prodromes that have been described. There is considerable variability of the prodromal manifestations that may occur before or during HAE attacks. We have not found any evidence that their sensitivity and specificity for accurately predicting such attacks has been studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843403     DOI: 10.2500/aap.2009.30.3278

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  6 in total

Review 1.  Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.

Authors:  Florence Ida Hsu; William Lumry; Marc Riedl; Raffi Tachdjian
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-13       Impact factor: 3.373

2.  Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency.

Authors:  Henriette Farkas; Lilian Varga
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-05-31

3.  The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease.

Authors:  Livia Savarese; Maria Francesca Freda; Raffaele De Luca Picione; Pasqaule Dolce; Raffaella De Falco; Maria Alessio; Mauro Cancian; Adriana Franzese; Maria Domenica Guarino; Roberto Perricone; Angelica Petraroli; Riccardo Senter; Claudia Traverso; Andrea Zanichelli; Eugenio Zito; Maria Bova
Journal:  Health Psychol Open       Date:  2020-12-08

4.  Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor.

Authors:  Lourdes Pastó Cardona; Ramon Lleonart Bellfill; Joaquim Marcoval Caus
Journal:  Appl Clin Genet       Date:  2010-12-03

5.  Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies.

Authors:  Richard G Gower; Paula J Busse; Emel Aygören-Pürsün; Amin J Barakat; Teresa Caballero; Mark Davis-Lorton; Henriette Farkas; David S Hurewitz; Joshua S Jacobs; Douglas T Johnston; William Lumry; Marcus Maurer
Journal:  World Allergy Organ J       Date:  2011-02       Impact factor: 4.084

Review 6.  The Story of Angioedema: from Quincke to Bradykinin.

Authors:  Avner Reshef; Mona Kidon; Iris Leibovich
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.